Pathological factors associated with survival benefit from adjuvant chemotherapy (ACT): A population-based study of bladder cancer

Christopher M. Booth, D. Robert Siemens, Xuejiao Wei, Yingwei Peng, David M. Berman, William J. Mackillop

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


Objective To evaluate whether pathological factors are associated with differential effect of adjuvant chemotherapy (ACT). Patients and Methods In this population-based retrospective cohort study, we linked electronic records of treatment and surgical pathology to the Ontario Cancer Registry. The study population included all patients with muscle-invasive bladder cancer undergoing cystectomy in Ontario 1994-2008. Factors associated with overall (OS) and cancer-specific survival (CSS) were evaluated using Cox proportional hazards. We tested for interaction between the following variables and ACT effect-size: N-stage, margin status, T-stage, and lymphovascular invasion (LVI). Results The study population included 2802 patients; 19% were treated with ACT. Interaction terms with ACT for OS/CSS are: N-stage (both P <0.001); margin status (P = 0.054/P = 0.048); T-stage (P = 0.509/P = 0.286); and LVI (P = 0.361/P = 0.405). Magnitude of effect for ACT was greater for patients with node-positive disease [OS: hazard ratio (HR) 0.56, 95% confidence interval (CI) 0.47-0.67; CSS: HR 0.60, 95% CI 0.49-0.72] than for patients with node-negative disease (OS: HR 0.80, 95% CI 0.61-1.03; CSS: HR 0.79, 95% CI 0.59-1.07). ACT was also associated with greater effect among patients with involved margins (OS: HR 0.45, 95% CI 0.33-0.62; CSS: HR 0.40, 95% CI 0.28-0.57) compared with patients with negative margins (OS: HR 0.75, 95% CI 0.65-0.87; CSS: HR 0.79, 95% CI 0.67-0.93). Conclusions In this population-based cohort study we observe evidence of interaction between ACT effect and nodal stage and surgical margin status. Our results suggest that patients at highest risk of disease recurrence may derive greatest benefit from ACT.

Original languageEnglish (US)
Pages (from-to)373-381
Number of pages9
JournalBJU International
Issue number3
StatePublished - Sep 1 2015
Externally publishedYes


  • bladder cancer
  • chemotherapy
  • outcomes research
  • predictive factors

ASJC Scopus subject areas

  • Urology
  • General Medicine


Dive into the research topics of 'Pathological factors associated with survival benefit from adjuvant chemotherapy (ACT): A population-based study of bladder cancer'. Together they form a unique fingerprint.

Cite this